Pfizer-BioNTech was said to have won a contract with the Philippines for the supply of the COVID-19 vaccine. It was reported that the country just signed a deal with the American multinational pharmaceutical and biotechnology company for 40 million doses of the vaccines.
The Philippines and Pfizer deal for coronavirus shots
As per Reuters, this is so far the biggest order of Pfizer COVID-19 vaccine from the Philippines. Secretary Carlito Galvez, the National Task Force chief against coronavirus, announced the deal with Pfizer on Sunday, June 20, and revealed that deliveries could be expected to begin in August.
In addition to this new order from Pfizer-BioNTech, the Philippines has now secured the delivery of 113 million doses of vaccine from five suppliers that include China's Sinovac (26 million doses), Moderna (20 million), Russia's Sputnik V (10 million) and AstraZeneca (17 million).
The vaccine supply in Manila is still limited and in some provinces, the government recorded a surge in COVID-19 cases, which complicates efforts to work up on the immunization drive. But with the upcoming Pfizer supply, officials are hoping that it will reach more people and eventually lessen the cases.
“We are very happy to report that the government and the management of Pfizer have finally concluded our negotiations, Philippine News Agency quoted Galvez as saying. “Health Secretary Francisco Duque and I signed yesterday (Saturday, June 19) the supply agreement for the biggest and most decisive deal we had for 2021.”
More vaccine jabs for the Filipinos
Galvez added that 20 million Filipinos will benefit from this Pfizer COVID-19 supply deal. The Philippines is not just waiting for deliveries from the American biotech company, but it is also expecting deliveries from the COVAX facility. In addition, a total of 16 million doses are coming from Jonhson & Johnson and Novavax as well.
Meanwhile, the Philippines will be allowing the administration of the Pfizer-BioNTech vaccines to youngsters ages 12 to 15. Their inoculation may begin later this year once the vaccine inventory expands and the priority group’s vaccinations are completed.


Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
Asian Stock Markets Rise Amid Wall Street Rally and U.S.-Iran Tensions
Wall Street Mixed as Apple Earnings Boost Nasdaq and Oil Prices Ease
Trump Rejects Iran Proposal as Tensions Persist Amid Fragile Ceasefire
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
AI Stocks Rally in Asia as Oil Surge and Hawkish Central Banks Shake Global Markets
EU Warns of Response as U.S. Considers 25% Tariffs on Car Imports
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Iran-U.S. Conflict Escalation Threatens Global Oil Supply and Economic Stability 



